233 related articles for article (PubMed ID: 17135587)
61. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
62. Use of menopausal hormones in the United States, 1992 through June, 2003.
Wysowski DK; Governale LA
Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
[TBL] [Abstract][Full Text] [Related]
63. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
64. Drugs for menopausal symptoms.
Med Lett Drugs Ther; 2016 Nov; 58(1507):142-145. PubMed ID: 27805574
[No Abstract] [Full Text] [Related]
65. In search of a middle ground: hormone therapy and its role in modern menopause management.
Shulman LP
Menopause; 2010; 17(5):898-9. PubMed ID: 20717059
[No Abstract] [Full Text] [Related]
66. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
Dew JE; Wren BG; Eden JA
Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
[TBL] [Abstract][Full Text] [Related]
67. Menopausal symptoms.
Koratamaddi LP; Prasad M
N Engl J Med; 2007 Mar; 356(11):1177; author reply 1177-8. PubMed ID: 17361492
[No Abstract] [Full Text] [Related]
68. Therapeutic principles in vulvovaginal dermatology.
Beecker J
Dermatol Clin; 2010 Oct; 28(4):639-48. PubMed ID: 20883909
[TBL] [Abstract][Full Text] [Related]
69. Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopause.
Marrai R; Lissi G; Togni S; Maramaldi G; Barbara M; Giacomelli L
Minerva Ginecol; 2017 Jun; 69(3):245-249. PubMed ID: 28420227
[TBL] [Abstract][Full Text] [Related]
70. Intravaginal estrogen creams and endometrial cancer: no causal association found.
Horwitz RI; Feinstein AR
JAMA; 1979 Mar; 241(12):1266-7. PubMed ID: 762793
[TBL] [Abstract][Full Text] [Related]
71. Bioidentical hormones for menopausal hormone therapy: variation on a theme.
Fugh-Berman A; Bythrow J
J Gen Intern Med; 2007 Jul; 22(7):1030-4. PubMed ID: 17549577
[TBL] [Abstract][Full Text] [Related]
72. Not time to abandon use of local vaginal hormone therapies.
Pinkerton JV; Kaunitz AM; Manson JE
Menopause; 2018 Aug; 25(8):855-858. PubMed ID: 29894370
[No Abstract] [Full Text] [Related]
73. Strategies for managing hot flashes.
Jassim GA
J Fam Pract; 2011 Jun; 60(6):333-9. PubMed ID: 21647469
[TBL] [Abstract][Full Text] [Related]
74. Systemic absorption and sustained effects of vaginal estrogen creams.
Martin PL; Yen SS; Burnier AM; Hermann H
JAMA; 1979 Dec; 242(24):2699-700. PubMed ID: 228093
[TBL] [Abstract][Full Text] [Related]
75. A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice.
Shulman LP; Portman DJ; Lee WC; Balu S; Joshi AV; Cobden D; Wang Q; Pashos CL
J Womens Health (Larchmt); 2008 May; 17(4):569-78. PubMed ID: 18429700
[TBL] [Abstract][Full Text] [Related]
76. Genitourinary Syndrome Of Menopause and Vaginal Estrogen Use.
Steele NM; Ledbetter CA; Bernier F
Urol Nurs; 2016; 36(2):59-65, 71. PubMed ID: 27281861
[TBL] [Abstract][Full Text] [Related]
77. Hormone Therapy for Postmenopausal Women.
Pinkerton JV
N Engl J Med; 2020 Jan; 382(5):446-455. PubMed ID: 31995690
[No Abstract] [Full Text] [Related]
78. Extended duration use of menopausal hormone therapy.
Kaunitz AM
Menopause; 2014 Jun; 21(6):679-81. PubMed ID: 24398408
[TBL] [Abstract][Full Text] [Related]
79. Management of Menopausal Symptoms for Women Who Are at High Risk of Thrombosis.
Pinkerton JV; James AH
Clin Obstet Gynecol; 2018 Jun; 61(2):260-268. PubMed ID: 29419532
[TBL] [Abstract][Full Text] [Related]
80. An alternative approach for the treatment of vaginal atrophy.
Quaranta L; Ottolina J; Parma M; Chionna R; Sileo F; Dindelli M; Origoni M; Candiani M; Salvatore S
Minerva Ginecol; 2014 Aug; 66(4):377-81. PubMed ID: 25020056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
